Completed OBSERVATIONAL NCT04128878

Improvement in Endothelial Dysfunction After Initiation of Anti-arrhythmic Therapy in Atrial Fibrillation Patients

Sponsor: Samir Saba

Updated 7 times since 2019 Last updated: Jan 11, 2021 Started: May 1, 2019 Primary completion: Dec 31, 2020 Completion: Dec 31, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04128878, this observational or N/A phase trial focuses on Atrial Fibrillation and remains completed. Sponsored by Samir Saba, it has been updated 7 times since 2019, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Feb 2021 — Jul 2024 [monthly]

Completed

Status: Recruiting → Completed
Jan 2021 — Feb 2021 [monthly]

Recruiting
Dec 2020 — Jan 2021 [monthly]

Recruiting

▶ Show 2 earlier versions

Jul 2020 — Dec 2020 [monthly]

Recruiting
Nov 2019 — Jul 2020 [monthly]

Recruiting

First recorded

May 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Samir Saba

Data source: University of Pittsburgh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pittsburgh, United States